SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy -- Ignore unavailable to you. Want to Upgrade?


To: Jim Oravetz who wrote (330)3/1/2006 12:23:25 PM
From: Jim Oravetz  Read Replies (3) | Respond to of 370
 
Vion Pharma 4Q Loss Narrows To $4.7M From $5.2M
DOW JONES NEWSWIRES
February 28, 2006 8:34 a.m.

Vion Pharmaceuticals Inc.'s (VION) fourth-quarter loss narrowed to $4.7 million, or 7 cents a share, from $5.2 million, or 9 cents.

The New Haven, Conn-based drug development company said revenue rose to $5,000 from $4,000.

The company ended the year with $52.8 million in cash and cash equivalents.